MedTrace Logo

The Canadian/US Integrative Oncology Study

NCT02494037 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-12-14

No results posted yet for this study

Summary

This study describes the survival outcomes of advanced stage breast, colorectal, ovarian and pancreatic cancer patients receiving advanced integrative oncology (AIO) treatment at participating North American integrative oncology clinics. This study also aims to describe the integrative treatments recommended by naturopathic doctors (NDs) for these participants alongside their conventional care treatments. Sub-studies will evaluate health-related quality of life, cost of cancer care, and qualitative experience of care in a subset of Canadian participants.

Conditions

  • Breast Neoplasms
  • Colorectal Neoplasms
  • Pancreatic Neoplasms
  • Ovarian Neoplasms

Sponsors & Collaborators

  • Bastyr University

    collaborator OTHER

  • Lotte & John Hecht Memorial Foundation

    collaborator OTHER

  • The Canadian College of Naturopathic Medicine

    lead OTHER

Principal Investigators

  • Dugald Seely, ND, MSc · Canadian College of Naturopathic Medicine

  • Leanna Standish, ND, PhD, FABNO · Bastyr University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2022-03-15
Completion
2023-12-01

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02494037 on ClinicalTrials.gov